APA (7th ed.) Citation

PJ, S., EH, T., J, R. P., R, V. K., A, P., U, G., . . . D, A. (2002). GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 13(12), 1853. https://doi.org/10.1093/annonc/mdf316

Chicago Style (17th ed.) Citation

PJ, Souquet, Tan EH, Rodrigues Pereira J, Van Klaveren R, Price A, Gatzemeier U, Jaworski M, Burillon JP, and Aubert D. "GLOB-1: A Prospective Randomised Clinical Phase III Trial Comparing Vinorelbine-cisplatin with Vinorelbine-ifosfamide-cisplatin in Metastatic Non-small-cell Lung Cancer Patients." Annals of Oncology : Official Journal of the European Society for Medical Oncology 13, no. 12 (2002): 1853. https://doi.org/10.1093/annonc/mdf316.

MLA (9th ed.) Citation

PJ, Souquet, et al. "GLOB-1: A Prospective Randomised Clinical Phase III Trial Comparing Vinorelbine-cisplatin with Vinorelbine-ifosfamide-cisplatin in Metastatic Non-small-cell Lung Cancer Patients." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 13, no. 12, 2002, p. 1853, https://doi.org/10.1093/annonc/mdf316.